查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1941220

生殖遗传学市场报告：按产品类型、手术类型、技术、应用和地区划分（2026-2034 年）

Reproductive Genetics Market Report by Product Type, Procedure Type, Technology, Application, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

2025年全球生殖遗传学市场规模为91亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到622亿美元，2026年至2034年的复合年增长率（CAGR）为23.87%。大众对遗传疾病的认识和了解不断提高、医疗保健服务的普及以及由于出生率上升而导致的辅助生殖技术（ART）使用增加，是推动生殖遗传学市场份额增长的主要因素。

生殖遗传学市场趋势：

全球市场的主要驱动力是大众对遗传疾病日益增长的认知和理解。此外，随着医疗保健服务的普及，越来越多的父母计划进行基因检测，以了解其未来子女的遗传疾病风险。出生率的上升推动了辅助生殖技术（ART）的使用，例如体外受精（IVF）和代孕，这对市场前景十分有利。相应地，先进基因检测技术的持续发展，例如次世代定序（NGS）和高解析度微阵列，也推动了市场成长。此外，女性生育年龄的成长也增加了染色体异常的风险，这也推动了市场发展。同时，多个国家的政府加大了对基因研究和检测的支持力度，也促进了市场成长。此外，基因测序检测价格的不断下降和普及也推动了市场发展。成长要素包括收入水准的提高（尤其是在开发中国家）、提供消费者基因检测的机构的增加、个人化医疗领域的持续创新以及广泛的研发活动。

本报告解答的关键问题

  • 生殖遗传学市场规模有多大？
  • 生殖遗传学市场的未来前景如何？
  • 推动生殖遗传学市场发展的关键因素是什么？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 二手资讯
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 调查方法

第三章执行摘要

第四章 引言

第五章：全球生殖遗传市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 按产品类型分類的市场区隔

  • 成套工具
  • 检查室自建检测方法（LDT）
  • 试剂和耗材

第七章 按测试类型分類的市场区隔

  • 携带者筛检
  • 产前筛检
  • 胚胎着床前遗传学检测
  • 不孕症基因检测

第八章 按技术分類的市场细分

  • 次世代定序
  • 聚合酵素链锁反应
  • 原位杂合反应（ISH/FISH）
  • 微阵列

第九章 按应用分類的市场细分

  • 非整倍体
  • 染色体结构异常
  • 单基因疾病
  • 其他的

第十章 按地区分類的市场细分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十一章 驱动因素、限制因素与机会

第十二章 价值链分析

第十三章 波特五力分析

第十四章：定价分析

第十五章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Bangkok Genomics Innovation Public Company Limited
    • Centogene NV
    • Fulgent Genetics Inc.
    • Igenomix（Vitrolife Group）
    • Invitae Corporation
    • Laboratory Corporation of America Holdings
    • PerkinElmer Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A10134

The global reproductive genetics market size reached USD 9.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 62.2 Billion by 2034, exhibiting a growth rate (CAGR) of 23.87% during 2026-2034. The growing awareness and understanding of genetic disorders among the masses, the rising adoption of preventive healthcare, and the increasing fertility rates leading to a higher uptake of assisted reproductive technologies (ART) represent some of the key factors driving the reproductive genetics market share.

Reproductive Genetics Market Analysis:

  • Major Market Drivers: The market for reproductive genetics is driven by increasing awareness of inherited disorders, increasing use of sophisticated genetic testing, and heightened demand for customized fertility therapies. Advanced gene sequencing and diagnostic technologies, along with changing reproductive healthcare infrastructure, are pushing adoption and enhancing access to early diagnosis and intervention solutions.
  • Key Market Trends: Some of the emerging trends are non-invasive prenatal testing, preimplantation genetic testing, and implementation of artificial intelligence in diagnostics. Personalized reproductive healthcare, growth in genetic counseling services, and emphasis on predictive analytics are transforming the market. Growing partnerships among research centers and clinics further drive innovation and patient-centric reproductive solutions.
  • Competitive Landscape: The market is marked by competition based on innovation, with companies banking on technology improvement, quality of services, and strategic partnerships. Firms invest their efforts in increasing diagnostic services, precision, and patient experience. Research institutions and health providers are the usual partners in efforts to increase market presence and reach new patient bases.
  • Challenges and Opportunities: Challenges are presented in the form of ethical issues, regulatory hurdles, and the expense of sophisticated genetic testing. Low awareness in some areas also holds back adoption. Oppositely, opportunities present themselves in creating cost-effective testing options, increasing genetic counseling, and applying AI and machine learning to enhance accuracy, accessibility, and personalized reproductive healthcare outcomes.

Reproductive genetics refers to the branch of genetics that focuses on the study of genetic information and its impact on reproductive health and outcomes. It involves the analysis and understanding of genetic factors related to fertility, pregnancy, and the transmission of genetic disorders from parents to their offspring. Reproductive genetics encompasses various techniques and technologies aimed at identifying and managing genetic conditions during the reproductive process. Screening individuals or couples for specific genetic mutations or carrier status to assess the risk of passing on genetic disorders to their children. In assisted reproductive technologies such as in vitro fertilization (IVF), PGD involves the analysis of embryos for genetic abnormalities before their implantation in the uterus, helping to select embryos without specific genetic disorders. Reproductive genetics helps assess the risk of transmitting genetic disorders to offspring by identifying carrier status or the presence of specific genetic mutations in individuals or couples.

Reproductive Genetics Market Trends:

The global market is primarily driven by the growing awareness and understanding of genetic disorders among the masses. Also, the rising adoption of preventive healthcare leading to a higher number of prospective parents undergoing genetic testing to understand the risks of genetic disorders in their future children is fueling the market. With the increasing fertility rates, there is a higher uptake of assisted reproductive technologies (ART) such as In-Vitro Fertilization (IVF) and surrogacy, which is creating a positive market outlook. In line with this, continual technological developments in advanced genetic testing techniques such as Next-Generation Sequencing (NGS) and high-resolution microarrays are stimulating the market. Moreover, the increasing maternal age resulting in a higher susceptibility of chromosomal abnormalities in women is providing an impetus to the market. In addition to this, governments of several countries are increasingly supporting genetic research and testing, thereby catalyzing the growth of the market. The market is further driven by the rising affordability of genomic sequencing procedures, resulting in higher accessibility among the masses. Some of the other factors contributing to the market include inflating income levels, particularly in developing countries, the proliferation of organizations offering direct-to-consumer genetic tests, continual innovations in personalized medicine, and extensive research and development (R&D) activities.

Key Market Segmentation:

Product Type Insights:

  • Kits
  • Laboratory Developed Tests (LDT)
  • Reagents and Consumables

Procedure Type Insights:

  • Carrier Screening
  • Pre-Natal Screening
  • Pre-Implantation Genetic Testing
  • Infertility Genetic Testing

Technology Insights:

  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • In Situ Hybridization (ISH/FISH)
  • Microarray

Application Insights:

  • Aneuploidy
  • Structural Chromosomal Abnormality
  • Single Gene Disorder
  • Others

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for reproductive genetics. Some of the factors driving the North America reproductive genetics market included its continual technological advancements in the field of genetics, the rising adoption of preventive healthcare high healthcare expenditure, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global reproductive genetics market. Detailed profiles of all major companies have been provided. Some of the companies covered include Bangkok Genomics Innovation Public Company Limited, Centogene N.V., Fulgent Genetics Inc., Igenomix (Vitrolife Group), Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer Inc., Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1.How big is the reproductive genetics market?
  • 2.What is the future outlook of reproductive genetics market?
  • 3.What are the key factors driving the reproductive genetics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Reproductive Genetics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Laboratory Developed Tests (LDT)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Reagents and Consumables
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Procedure Type

  • 7.1 Carrier Screening
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pre-Natal Screening
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Pre-Implantation Genetic Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Infertility Genetic Testing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Next-Generation Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Polymerase Chain Reaction
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 In Situ Hybridization (ISH/FISH)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Microarray
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Aneuploidy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Structural Chromosomal Abnormality
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Single Gene Disorder
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bangkok Genomics Innovation Public Company Limited
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Centogene N.V.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Fulgent Genetics Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Igenomix (Vitrolife Group)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Invitae Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Laboratory Corporation of America Holdings
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 PerkinElmer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Thermo Fisher Scientific Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio

List of Figures

  • Figure 1: Global: Reproductive Genetics Market: Major Drivers and Challenges
  • Figure 2: Global: Reproductive Genetics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Reproductive Genetics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Reproductive Genetics Market: Breakup by Product Type (in %), 2025
  • Figure 5: Global: Reproductive Genetics Market: Breakup by Procedure Type (in %), 2025
  • Figure 6: Global: Reproductive Genetics Market: Breakup by Technology (in %), 2025
  • Figure 7: Global: Reproductive Genetics Market: Breakup by Application (in %), 2025
  • Figure 8: Global: Reproductive Genetics Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Reproductive Genetics (Kits) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Reproductive Genetics (Kits) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Reproductive Genetics (Laboratory Developed Tests (LDT)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Reproductive Genetics (Laboratory Developed Tests (LDT)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Reproductive Genetics (Reagents and Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Reproductive Genetics (Reagents and Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Reproductive Genetics (Carrier Screening) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Reproductive Genetics (Carrier Screening) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Reproductive Genetics (Pre-Natal Screening) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Reproductive Genetics (Pre-Natal Screening) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Reproductive Genetics (Pre-Implantation Genetic Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Reproductive Genetics (Pre-Implantation Genetic Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Reproductive Genetics (Infertility Genetic Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Reproductive Genetics (Infertility Genetic Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Reproductive Genetics (Next-Generation Sequencing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Reproductive Genetics (Next-Generation Sequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Reproductive Genetics (Polymerase Chain Reaction) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Reproductive Genetics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Reproductive Genetics (In Situ Hybridization (ISH/FISH)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Reproductive Genetics (In Situ Hybridization (ISH/FISH)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Reproductive Genetics (Microarray) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Reproductive Genetics (Microarray) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Reproductive Genetics (Aneuploidy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Reproductive Genetics (Aneuploidy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Reproductive Genetics (Structural Chromosomal Abnormality) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Reproductive Genetics (Structural Chromosomal Abnormality) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Reproductive Genetics (Single Gene Disorder) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Reproductive Genetics (Single Gene Disorder) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Reproductive Genetics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Reproductive Genetics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: North America: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: North America: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: United States: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: United States: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Canada: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Canada: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Asia-Pacific: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Asia-Pacific: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: China: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: China: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Japan: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Japan: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: India: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: India: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: South Korea: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: South Korea: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Australia: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Australia: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Indonesia: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Indonesia: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Others: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Others: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Europe: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Europe: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Germany: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Germany: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: France: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: France: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: United Kingdom: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: United Kingdom: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Italy: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Italy: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Spain: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Spain: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Russia: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Russia: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Others: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Others: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Latin America: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Latin America: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Brazil: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Brazil: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Mexico: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Mexico: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Others: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Others: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Middle East and Africa: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Middle East and Africa: Reproductive Genetics Market: Breakup by Country (in %), 2025
  • Figure 87: Middle East and Africa: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Global: Reproductive Genetics Industry: Drivers, Restraints, and Opportunities
  • Figure 89: Global: Reproductive Genetics Industry: Value Chain Analysis
  • Figure 90: Global: Reproductive Genetics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Reproductive Genetics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Reproductive Genetics Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Reproductive Genetics Market Forecast: Breakup by Procedure Type (in Million USD), 2026-2034
  • Table 4: Global: Reproductive Genetics Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 5: Global: Reproductive Genetics Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 6: Global: Reproductive Genetics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Reproductive Genetics Market: Competitive Structure
  • Table 8: Global: Reproductive Genetics Market: Key Players